The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya
Backgound: Sulphadoxine/sulphalene-pyrimethamine (SP) was adopted in Kenya as first line therapeutic for uncomplicated malaria in 1998. By the second half of 2003, there was convincing evidence that SP was failing and had to be replaced. Despite several descriptive investigations of policy change an...
Hlavní autoři: | Amin, A, Zurovac, D, Kangwana, B, Greeenfield, J, Otieno, D, Akhwale, W, Snow, R |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
BioMed Central
2007
|
Témata: |
Podobné jednotky
-
The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya.
Autor: Amin, A, a další
Vydáno: (2007) -
The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya
Autor: Otieno Dorothy N, a další
Vydáno: (2007-05-01) -
The decline in paediatric malaria admissions on the coast of Kenya
Autor: Okiro, E, a další
Vydáno: (2007) -
Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study
Autor: Zurovac, D, a další
Vydáno: (2007) -
Why don't health workers prescribe ACT? A qualitative study of factors affecting the prescription of artemether-lumefantrine
Autor: Wasunna, B, a další
Vydáno: (2008)